Sign in
RVLPQ Stock Price, Chart, Stats & News
RVL Pharmaceuticals plc
Save
RVL Pharmaceuticals plc (RVLPQ) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
RVLPQ chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 80.98% |
Operating margin | -118.64% |
Pretax margin | -104.00% |
Net margin | -103.96% |
Effective tax rate | 0.04% |
ROA | -40.22% |
ROE | -80.88% |
D/E | 1.13x |
Interest coverage ratio | -18.97x |
RVLPQ valuation
P/E | – |
P/S | 0.00x |
P/B | 0.00x |
P/CF | -0.00x |
P/FCF | -0.00x |
P/OCF | -0.00x |
PEG | -0.00x |
EV multiple | 0.27x |
About
RVL Pharmaceuticals plc operates as a specialized drug company, dedicated to innovating and marketing pharmaceutical solutions for patient groups with unmet needs in the ophthalmic and medical aesthetics domains. The firm's activities extend across the United States, Argentina, and Hungary. Its principal commercial offering is Upneeq (RVL-1201), an ophthalmic solution containing oxymetazoline hydrochloride, specifically formulated to address acquired blepharoptosis, or drooping eyelids, in adults.
Similar securities
Based on sector and market capitalization
Report issue